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SUMMARY Axillary hyperhidrosis poses a serious problem to the 
affected patients. So far, the conservative measures employed 
seem to be disappointing, operations with axillary skin excision, 
undermining and/or skin reconstruction may cause secondary 
functional and cosmetic problems, whereas botulinum A toxin 
injections need to be repeated frequently. The aim of this study 
was to establish the safety, efficacy, and durability of subdermal 
(subcorial) suction sweat gland curettage in the treatment of axillary 
hyperhidrosis. So far, the method seems to be devoid of possible 
risks and drawbacks. In the last 4.5 years, 15 patients with axillary 
hyperhidrosis were operated on with the use of liposuction tools. 
First operations were performed in general anesthesia, then in 
tumescent anesthesia. The procedure of suction curettage was 
performed with the use of 3- to 4-mm wide liposuction cannulas. 
The patients were closely monitored during early stages of the 
healing process; then they were evaluated at 1 and 3 months, and 
finally at 1-4 years of the operation, when they were asked to assess 
the effects of the operation. Four patients had recurrence of the 
disease within 3 months; three of them were reoperated on, with 
good result. At 1-4 years of the operation, all our responders (ten 
of 15 patients) stated that the disease had completely subsided. 
The following complications were observed during the process of 
healing: hematomas, transient skin unevenness, and partial skin 
flap necrosis. In conclusion, subdermal suction curettage seems to 
be superior to botulinum A toxin injections by the effect durability, 
and to the surgical methods with skin excision and undermining by 
the probably lower complication rates.
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INTRODUCTION
 Axillary hyperhidrosis is a genetic, autosomal 
dominant hyperactivity of the eccrine glands of 
the axilla, resulting from the increased sudomotor 
impulses, generated mainly during waking hours 
by mental, emotional and sensory stimuli (1). The 
disease begins usually in puberty. The quantities 
of clear eccrine sweat are excessive, the disease 
may be defined as secreting over 125 mg/5 min in 
one armpit, measured gravimetrically. The hyper-
active glands do not show any pathologic chang-
es on histologic examination. The axillary and 
volar (palmoplantar) form of hyperhidrosis may 
be simultaneous. Because clothing is constantly 
stained, the work may be impaired, and social 
activities become difficult. Mapping of the axillary 
sweat gland is enabled by Minor’s technique of 
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iodine and starch, the resulting patterns constitut-
ing the basis for various methods of axillary resec-
tion techniques. 
Treatment of axillary hyperhidrosis
 Various conservative methods of hyperhidrosis 
treatment have been put forward. Topical applica-
tion of formaldehyde, aluminum sulfate, or alu-
minum-zirconium salts have been tried, whereas 
buffered 20% aluminum chloride hexahydrate ap-
plied under occlusion during sleep proved most ef-
ficient (1-4). Commercial antiperspirants are usu-
ally ineffective. Water iontophoresis, also with the 
addition of anticholinergics, is possible but difficult 
to perform in axillary region. Psychotherapy may 
also be considered (1-3). General medication like 
anticholinergics (glycopyrrolate, bornaprine HCl), 
calcium blockers, analgesics (propoxyphene), an-
tihypertonics (clonidine), or sedatives suppress 
sweating, however, usually at side effect produc-
ing dosages (1-4).
 Since 1996, when first papers concerning the 
use of botulinum A toxin injections in the treat-
ment of axillary hyperhidrosis were published, the 
treatment has gained wide acceptance (5). The 
treatment has proved to be efficient and simple, 
comprised intradermal or superficial subcutane-
ous injections of about 50 to 70 IU botulinum A 
exotoxin per axilla at 15 to 20 injection sites 1-2 
cm apart from each other (4,6-10). The first thera-
peutic effect may be visible after one week, while 
full suppression of sweating should take place af-
ter one month. The most serious drawback is the 
relatively short durability of the effect ranging from 
4 to 9 months, as injections usually need to be 
repeated after this period of time (4,10-12). 
 A number of surgical methods of axillary hyper-
hidrosis treatment have been proposed. Because 
of their possible risks, trial with one of pharmaco-
logical approaches should be suggested before 
undertaking surgery. Until the early 1960s, axillary 
hyperhidrosis was managed with sympathectomy, 
usually of upper thoracic ganglia II and III; later, 
endoscopic transthoracal sympathectomy was 
also proposed. However, it was more effective for 
palmar, and not routinely for axillary hyperhidrosis. 
Besides, the method could produce serious side 
effects (1-4). Sympathetic blockade and sclero-
therapy were also tried (3). Currently, the disease 
constitutes the indication exclusively for local axil-
lary ablative surgery. First observations concerning 
the cessation of sweating were made in patients 
who underwent radical mastectomy with extensive 
axillary dissection (1). In the early 1960s, Hurley 
and Shelley (13) described an operation based on 
mapping of the sweating loci. The central part of 
the locus was excised with transverse fusiform ex-
cision, usually measuring 5x2 cm. The surrounding 
skin was undermined and the glands were excised 
to the margins of each locus of sweating. Because 
of their greater dimensions apocrine glands are 
better visible, however, as they are closely mixed 
with eccrine glands, both are excised at the same 
time. A similar operation but with “zigzag” excision 
was proposed in Eldh-Fogdestam operation (1-
3,14). The Skoog-Thyresson method advocated 
wide skin incisions in the form of four flaps and 
broad glandular removal over the entire axilla 
by means of undermining and gland dissection 
(1-3,14). The broad excision of the full thickness 
axillary skin and closure with the use of Z-plasty 
was described in Bretteville-Jensen operation. In 
most advanced cases the excision of the whole 
axillary skin and coverage with the split thickness 
skin graft was suggested (1-3). All methods with 
excision and undermining were associated with 
possible complications such as hematoma, infec-
tion, wound dehiscence, skin necrosis, scar con-
tracture, or unacceptable cosmetic outcome. The 
idea of subcorial damage of sweat glands was 
originally employed in operations with the use of 
subcutaneous tissue shavers (safety razor) or cu-
rettes (15). Such operations have become easier 
to perform and less traumatic with the introduction 
of tumescent anesthesia and liposuction curettes. 
That is why the procedure of curettage of the axilla 
with liposuction cannulas performed in tumescent 
anesthesia (subcutaneous-subcorial sweat gland 
suction curettage) has gained wider acceptance. 
The method is considered to be relatively simple, 
almost completely free of complications, and ef-
fective for life (16,17).  
Aim of the study
 The aim of our study was to establish the safe-
ty, efficacy and durability of the subcorial-subcuta-
neous sweat gland suction curettage.
PATIENTS AND METHODS
 In our practice, 15 patients with axillary hyper-
hidrosis (13 women and two men) were operated 
on with the use of liposuction tools in the last 4.5 
years. The first three operations were performed 
in general anesthesia, and the following ones in 
infiltration tumescent anesthesia. Usually, the in-
jection of 100-250 ml of the anesthetic solution 
according to Klein formula was administered into 
one axillary region (18). The 500-ml anesthetic 
Bieniek et al.     Acta Dermatovenerol Croat
Treatment of axillary hyperhidrosis                   2005;13(4):212-218
214
mixture was usually composed of 0.5 g lidocaine, 
10 ml 8.4% bicarbonate and 0.5 mg adrenaline, 
dissolved in physiologic saline solution (0.9%) im-
medialtely before the intervention. 
 After short observation, the area of hyperhidro-
sis was outlined with a marker (Fig. 1). Infiltrations 
were performed with the use of rotation infusion 
pump or pressure bags and spinal needles (Fig. 2). 
The whole armpit was usually infiltrated within 5 to 
10 minutes. First generation cephalosporins were 
administered to prevent infectious complications. 
 The procedure on both armpits usually took 
30 to 45 minutes. After the procedure, axillary 
areas were covered with antibiotic ointment and 
abundant gauze dressing, pressed with elastic 
adhesive tape. Patients were instructed to avoid 
abduction of arms. On the next day the wounds 
were disinfected and another dressing was put in 
a similar manner. From the second postoperative 
day only minor dressings covering entrance holes 
were preferred. The healing process was usually 
monitored to day 7 of the operation. 
 All patients were called for follow-up examina-
tions after 1 and 3 months, whereas a group of 
patients operated on earlier were called after at 
least 1 to 4.5 years after the last operation (first or 
reoperation if done). On each visit patients were 
asked to comment on the operative results, thus 
allowing for qualifying the results as good or in-
sufficient, and making a unique scale of measur-
ing the effects. The grade of axillary sweating was 
also checked by observation lasting for about 3 
minutes. However, we found such observation 
not valid because of the emotional dependence 
of sweat secretion. Similarly, after first attempts, 
gravimetric testing was not used anymore be-
cause of possible fluctuations of the results and 
technical difficulties. Axillary skin was additionally 
observed to evaluate the possible disfigurement. 
RESULTS
 Patients accepted tumescent anesthesia and 
surgical interventions well. The prolonged analge-
sic effect of lidocaine tissue deposits after tumes-
cent anesthesia ensured almost painless postop-
erative period. Usually during the second day of 
Figure 1. The area of hyperhidrosis, comprising 
virtually the whole surface of the armpit, was 
outlined before the operation.
Figure 2. The tumescent anesthesia solution was 
injected with the use of spinal needle and peristaltic 
pump or pressure bag. After 10-15 minutes, the 
skin turned pale. 
 Surgical maneuvers were performed through 3-
4 mm long incisions, usually 3 in number, with the 
use of liposuction cannulas 3-4 mm in diameter 
(Fig. 3). Cannulas with one or two holes located on 
one side of the needle were needed. During the pro-
cedure the holes were directed to the skin surface. 
Figure 3. The 3-4 mm cannula with hole(s) 
located at one side was introduced through 2-3 
tiny incisions into subdermal plane. During the 
procedure of curretage, the hole was directed to 
the surface.
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the operation, the axillary skin looked almost un-
changed (Fig. 4). The wound heald completely in 
7 days. Patients resumed their daily routine in 2-7 
days.
 At 1 month, all patients were satisfied with the 
results, including those with impaired wound heal-
ing. The scars were usually inconspicuous and 
axillary skin looked normal (Fig. 5). At 3 months 
of the operation, four (26.6%) patients observed 
recurrence of the disease. Recurrent hyperhidro-
sis was noticed unilaterally in one and bilaterally 
in three patients. Three of them were reoperated 
on, with a longlasting good result, whereas one 
has been scheduled for reoperation (Table 1). The 
symptom free period lasted from 2 months to 4.5 
years, mean 20 months. During the late follow-up 
(at 1-4.5 years), all ten responders declared satis-
faction with the results (Table 1).  
 The healing process was impaired in 5 cases 
(Table 1). In two cases, hematomas developed to 
Figure 4. On postoperative day 2, the skin 
appeared almost unchanged.
Figure 5. Several weeks after the operation, 
the scars usually looked inconspicuous, and the 























1 F 30 Good Good No No Good 54
2 F 22 Good Good No No Good 37




4 F 30 Good Good No No Good 36
5 F 29 Good Good No Hematoma Good 30
6 F 24 Good Good No No Good 23
7 F 38 Good Good No Hematoma Good 18
8 F 27 Good Insufficient Yes No Good 12
9 M 34 Good Good No Transient 
unevenness
Good 13
10 F 36 Good Good No No Good 13
11 F 24 Good Insufficient Yes No Good 10
12 F 27 Good Insufficient Yes No Not known 7




14 F 25 Good Good No No Not known 5
15 F 25 Good Insufficient Planned No Not known 2
Table 1. Patients with axillary hyperhidrosis and their follow up after subcutaneous suction curettage
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Table 1. Sites of distant skin metastases (modified from Lookingbill et al. (2))
Primary site Sites of distant skin metastases
Breast Back, scalp, upper extremities, abdomen, neck, shoulders, lower extremities, flank, chest*, 
buttocks, face
Melanoma Chest, lower extremities, upper extremities, neck, scalp, abdomen, back, face, shoulders, 
buttocks, flank, genitalia
Unknown Lower extremities, abdomen, neck, scalp, face, back, upper extremities, genitalia, flank, chest
Lung Chest, abdomen, scalp, neck, back, face, upper extremities, lower extremities
Oral cavity Neck, scalp, face, chest, back, upper extremities
Colon and 
rectum
Chest, back, abdomen, scalp, face, genitalia
Urinary bladder Chest, flank, abdomen
Ovary Abdomen, lower extremities
Larynx Chest, abdomen
Kidney Scalp, face, neck, chest, upper extremities
Esophagus Chest, abdomen, scalp, shoulders, upper extremities, lower extremities
Nasal sinuses Scalp, neck, back, abdomen




Uterine cervix Chest, abdomen, genitalia
Pancreas Chest, abdomen, upper extremities
Stomach Chest
*contralateral chest wall involvement without ipsilateral involvement; **site not specified in one 
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dissolve completely in 10 days (Fig. 6). In 3 cases, 
transient hardening (fibrosis) of the subdermal 
plane developed, causing surface unevenness. It 
usually began in the second week postoperatively 
and subsided completely in 1-3 months (Fig. 7). 
Two patients developed areas of skin necrosis bi-
laterally. In one case the areas measured 2x2 cm 
and 1x1 cm, and in the other 1x1 cm and 0.5x1 cm. 
The problem was diagnosed when the central part 
of the skin in the armpit dome appeared ischemic 
on the first and second day of the procedure. The 
healing process led to spontaneous demarcation 
of devitalized tissues, which was quite clear on 
postoperative day 4-6. In one case, a large area of 
necrotic skin was excised, while the other side was 
left without additional intervention. Approximately 
5 weeks of the operation, the secondary intention 
healing was completed. The scars did not affect 
the mobility of arms. In the other case, minor areas 
of necrosis separated spontaneously (Fig. 8) and 
healed secondarily to leave nearly invisible traces. 
 DISCUSSION
 Many patients and physicians may not be aware 
that successful treatment of axillary hyperhidrosis 
is possible. Nevertheless, contemporary dermato-
surgery offers a variety of efficient solutions of the 
problem. The most popular are botulinum A exo-
toxin injections, employed widely because of sim-
plicity and good outcome. Subcutaneous ablation 
of the axilla in tumescent anesthesia (subcutane-
ous-subcorial sweat gland suction curettage) is 
also regarded as a simple and effective measure 
(16,17). Side effects are considered to be minor, 
and patients’ acceptance is high (19). Scars are 
usually minimal and well hidden, infections are 
rare, and recovery is rapid. Profound hemostasis 
characteristic of tumescent anesthesia diminishes 
the risk of hematoma, and prolonged anesthesia 
provides for a comfortable postoperative recovery 
(17,18). Opinions about the durability of the pro-
cedure differ to some extent. It is regarded to last 
for at least 24 months (19), or to be permanent 
(20). Nevertheless, such a surgical procedure has 
lately gained more advocates (20).    
 Nevertheless one should take into account cer-
tain risks and drawbacks. In our series of 15 pa-
tients, there were 2 cases of skin necrosis, 4 cases 
of inadequate result, 2 cases of hematoma, and 3 
cases of transient subdermal hardening. All these 
problems affected nine patients (five with healing 
complications and another four with primarily insuf-
ficient result). Taking these problems into account, 
we have concluded that the operation should be 
neither too aggressive (to avoid delayed healing) 
Figure 6. Hematomas were observed in two cases 
but resolved spontaneously without any further 
surgical intervention.
Figure 7. The surface uneveness and sub-
cutaneous fibrosis were observed in three cases, 
to completely disappear within three months.
Figure 8. Partial skin necrosis was observed in two 
cases. Two weeks of the operation, spontaneous 
healing of the central defect measuring 1x1cm 
with subcutaneous hardening occurred. Finally, 
the scar appeared inconspicuous and unevenness 
subsided.
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nor too delicate (to ensure adequate effect) to ob-
tain a satisfactory outcome. We found avoidance 
of too wide skin flap separation from the underly-
ing tissues and preservation of the fibrous septa 
connecting the subcutanous tissue and the skin, 
at least to some extent, to be of special impor-
tance. In the cases complicated with skin necro-
sis, the skin undermining was almost complete all 
over the armpit area. The other possible cause of 
the problem was the lack of proper compression 
of dressing, due to the patient hyperactivity during 
the night. The problem may possibly be ameliorat-
ed by restricting the patient hyperactivity with the 
use of strong sedatives. Ischemia sets in immedi-
ately upon the operation; proper local and general 
treatment performed on the next days could not 
revitalize the already necrotic tissues. In our male 
patient, a disfiguring scar remained, however, it 
did not affect the patient’s later acceptance of the 
procedure, possibly because of the sex. In our fe-
male patient with minor areas of skin necrosis, the 
remaining scars were barely visible. 
 All patients were operated on with a similar 
technique; finally, the symptoms of the disease re-
curred in 3 months in four patients, three of them 
with the extremely abundant form of hyperhidrosis. 
One may suppose that such aggressive hyperhi-
drosis may also be more resistant to curettage. To 
avoid recurrence, particularly thorough curettage 
should be considered in such cases. 
 The axillary subdermal scarring did not seem to 
be frequent (21). Nonetheless, it was observed in 
three patients in our series (Table 1). In all cases it 
was transient and subsided within 3 months. Dur-
ing this period, good relationship with the patients 
and reassurance permitting them to handle the 
condition properly proved to be very important. 
To accelerate the maturation of subdermal fibro-
sis, patients were prescribed conservative treat-
ment with heating, massage, gels and ointments 
with onion flavonoids or heparin. We feel that such 
measures may be undertaken not only in the treat-
ment of the already existent subdermal scarring 
but also in its prophylaxis. In our opinion, it should 
begin 3 weeks after the operation and be contin-
ued until the third month. 
 Another interesting side effect, also found in 
some patients, was slower regrowth of the axillary 
hair. The exact number of such cases is so far not 
known, because at first we failed to pay due at-
tention to the symptom. At the beginning we per-
formed Minor’s starch-iodine trials before the inter-
vention. With time, as we did not find them benefi-
cial, they were abandoned. The trials proved to be 
time consuming and difficult to perform. They also 
seemed to be unnecessary, because of the ease 
of reaching virtually the entire area of the armpit 
by the working instrument, without significant risk 
enhancement. The curettage area limitation only 
to the diagnosed loci of hypersecretion could, in 
our opinion, unnecessarily diminish the operation 
efficacy. 
 Despite possible complications, in comparison 
with surgical methods based on skin excision and 
undermining, subdermal suction curettage seems 
to be more tissue-sparing, atraumatic, and prob-
ably associated with a lower complication rate. 
The mean durability of the results observed so far 
in our series has reached 20 months and makes 
the method superior to botulinum A toxin injec-
tions (Table 1). As some of our patients have been 
symptom free for as long as 54 months, and the 
majority of them for more than one year, we hope 
that the good effect will hold for the lifetime.  
CONCLUSION
 The procedure (surgical treatment of axillary 
hyperhidrosis with liposuction equipment) may be 
associated with complications such as hematoma, 
transient surface unevenness, partial skin necro-
sis, or recurrence of the disease. Despite the pos-
sible risks, subcorial suction curettage is generally 
well tolerated by the patients, and relatively safe 
and efficacious for a long time as the treatment of 
axillary hyperhidrosis.
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